Immune checkpoint therapy: Forging ahead.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36350993.
- Also identified by DOI 10.1126/scitranslmed.adf2947.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Spatiotemporal immune monitoring in clinical trials and reverse translation will help to determine optimal combination immune therapies to cure cancer.
Medical subject headings
- Immunotherapy
- Neoplasms